157 related articles for article (PubMed ID: 20670954)
1. The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease.
Dierks C; Adrian F; Fisch P; Ma H; Maurer H; Herchenbach D; Forster CU; Sprissler C; Liu G; Rottmann S; Guo GR; Katja Z; Veelken H; Warmuth M
Cancer Res; 2010 Aug; 70(15):6193-204. PubMed ID: 20670954
[TBL] [Abstract][Full Text] [Related]
2. Premature terminal differentiation protects from deregulated lymphocyte activation by ITK-Syk.
Bach MP; Hug E; Werner M; Holch J; Sprissler C; Pechloff K; Zirlik K; Zeiser R; Dierks C; Ruland J; Jumaa H
J Immunol; 2014 Feb; 192(3):1024-33. PubMed ID: 24376268
[TBL] [Abstract][Full Text] [Related]
3. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.
Streubel B; Vinatzer U; Willheim M; Raderer M; Chott A
Leukemia; 2006 Feb; 20(2):313-8. PubMed ID: 16341044
[TBL] [Abstract][Full Text] [Related]
4. The lymphoma-associated fusion tyrosine kinase ITK-SYK requires pleckstrin homology domain-mediated membrane localization for activation and cellular transformation.
Rigby S; Huang Y; Streubel B; Chott A; Du MQ; Turner SD; Bacon CM
J Biol Chem; 2009 Sep; 284(39):26871-81. PubMed ID: 19535334
[TBL] [Abstract][Full Text] [Related]
5. Signaling of the ITK (interleukin 2-inducible T cell kinase)-SYK (spleen tyrosine kinase) fusion kinase is dependent on adapter SLP-76 and on the adapter function of the kinases SYK and ZAP70.
Hussain A; Mohammad DK; Gustafsson MO; Uslu M; Hamasy A; Nore BF; Mohamed AJ; Smith CI
J Biol Chem; 2013 Mar; 288(10):7338-50. PubMed ID: 23293025
[TBL] [Abstract][Full Text] [Related]
6. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.
Pechloff K; Holch J; Ferch U; Schweneker M; Brunner K; Kremer M; Sparwasser T; Quintanilla-Martinez L; Zimber-Strobl U; Streubel B; Gewies A; Peschel C; Ruland J
J Exp Med; 2010 May; 207(5):1031-44. PubMed ID: 20439541
[TBL] [Abstract][Full Text] [Related]
7. Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene.
Liang PI; Chang ST; Lin MY; Hsieh YC; Chu PY; Chen CJ; Lin KJ; Jung YC; Hwang WS; Huang WT; Chang WC; Ye H; Chuang SS
Int J Clin Exp Pathol; 2014; 7(9):6097-107. PubMed ID: 25337257
[TBL] [Abstract][Full Text] [Related]
8. Translocation-generated ITK-FER and ITK-SYK fusions induce STAT3 phosphorylation and CD69 expression.
Fathi NN; Mohammad DK; Görgens A; Andaloussi SE; Zain R; Nore BF; Smith CIE
Biochem Biophys Res Commun; 2018 Oct; 504(4):749-752. PubMed ID: 30217447
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol-3-kinase-dependent phosphorylation of SLP-76 by the lymphoma-associated ITK-SYK fusion-protein.
Hussain A; Faryal R; Nore BF; Mohamed AJ; Smith CI
Biochem Biophys Res Commun; 2009 Dec; 390(3):892-6. PubMed ID: 19850008
[TBL] [Abstract][Full Text] [Related]
10. TEC family kinases in health and disease--loss-of-function of BTK and ITK and the gain-of-function fusions ITK-SYK and BTK-SYK.
Hussain A; Yu L; Faryal R; Mohammad DK; Mohamed AJ; Smith CI
FEBS J; 2011 Jun; 278(12):2001-10. PubMed ID: 21518255
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas.
Feldman AL; Sun DX; Law ME; Novak AJ; Attygalle AD; Thorland EC; Fink SR; Vrana JA; Caron BL; Morice WG; Remstein ED; Grogg KL; Kurtin PJ; Macon WR; Dogan A
Leukemia; 2008 Jun; 22(6):1139-43. PubMed ID: 18401419
[TBL] [Abstract][Full Text] [Related]
12. ITK/SYK translocation in angioimmunoblastic T-cell lymphoma.
Attygalle AD; Feldman AL; Dogan A
Am J Surg Pathol; 2013 Sep; 37(9):1456-7. PubMed ID: 24076779
[No Abstract] [Full Text] [Related]
13. [Follicular variant of peripheral T-cell lymphoma: a clinicopathologic and genetic study of 2 cases].
Zhan HQ; Zhu XZ; Li XQ; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):32-6. PubMed ID: 21429356
[TBL] [Abstract][Full Text] [Related]
14. Depletion of STAT5 blocks TEL-SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice.
Sprissler C; Belenki D; Maurer H; Aumann K; Pfeifer D; Klein C; Müller TA; Kissel S; Hülsdünker J; Alexandrovski J; Brummer T; Jumaa H; Duyster J; Dierks C
Blood Cancer J; 2014 Aug; 4(8):e240. PubMed ID: 25148222
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection.
He F; Yao H; Xiao Z; Han J; Zou J; Liu Z
Mol Immunol; 2014 May; 59(1):30-8. PubMed ID: 24462896
[TBL] [Abstract][Full Text] [Related]
16. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Kimura H; Date M; Hamaguchi Y; Hasegawa M; Hau KT; Fujimoto M; Takehara K; Matsushita T
J Dermatol Sci; 2014 Jun; 74(3):214-21. PubMed ID: 24679982
[TBL] [Abstract][Full Text] [Related]
17. Peripheral T cell lymphoma: new model + new insight.
Mulloy JC
J Exp Med; 2010 May; 207(5):911-3. PubMed ID: 20439538
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness.
Matsubara S; Li G; Takeda K; Loader JE; Pine P; Masuda ES; Miyahara N; Miyahara S; Lucas JJ; Dakhama A; Gelfand EW
Am J Respir Crit Care Med; 2006 Jan; 173(1):56-63. PubMed ID: 16192454
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of src family gene for tyrosine-kinase p59fyn in CD4-CD8- T cells of mice with a lymphoproliferative disorder.
Katagiri T; Urakawa K; Yamanashi Y; Semba K; Takahashi T; Toyoshima K; Yamamoto T; Kano K
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10064-8. PubMed ID: 2513573
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of a K390R ITK kinase dead transgenic mouse--implications for ITK as a therapeutic target.
Deakin A; Duddy G; Wilson S; Harrison S; Latcham J; Fulleylove M; Fung S; Smith J; Pedrick M; McKevitt T; Felton L; Morley J; Quint D; Fattah D; Hayes B; Gough J; Solari R
PLoS One; 2014; 9(9):e107490. PubMed ID: 25250764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
